Similar articles

• Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage.

  Tellez H, Bauer RB. Tellez H, et al. Stroke. 1973 Jul-Aug;4(4):541-6. doi: 10.1161/01.str.4.4.541. Stroke. 1973. PMID: 4579368 Clinical Trial. No abstract available.
• Double-blind study of the effects of dexamethasone on acute stroke.

  Patten BM, Mendell J, Bruun B, Curtin W, Carter S. Patten BM, et al. Neurology. 1972 Apr;22(4):377-83. doi: 10.1212/wnl.22.4.377. Neurology. 1972. PMID: 4552717 Clinical Trial. No abstract available.
• Double-blind evaluation of glycerol therapy in acute cerebral infarction.

  Mathew NT, Rivera VM, Meyer JS, Charney JZ, Hartmann A. Mathew NT, et al. Lancet. 1972 Dec 23;2(7791):1327-9. doi: 10.1016/s0140-6736(72)92775-4. Lancet. 1972. PMID: 4118203 Clinical Trial. No abstract available.
• Role of dexamethasone in the outcome from acute stroke.

  Kumar N, Jain S, Maheshwari MC. Kumar N, et al. J Assoc Physicians India. 1989 May;37(5):315-7. J Assoc Physicians India. 1989. PMID: 2693439 Review.
• Thrombolytic therapy in stroke: possibilities and hazards.

  Del Zoppo GJ, Zeumer H, Harker LA. Del Zoppo GJ, et al. Stroke. 1986 Jul-Aug;17(4):595-607. doi: 10.1161/01.str.17.4.595. Stroke. 1986. PMID: 3526644 Review. No abstract available.